These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34414245)

  • 1. The Effects of Catheter Ablation Therapy on Medication Use and Expenditures in Patients with Atrial Fibrillation.
    Reynolds MR; David G; Gunnarsson C; March JL; Hao SC
    J Health Econ Outcomes Res; 2014; 2(1):15-28. PubMed ID: 34414245
    [No Abstract]   [Full Text] [Related]  

  • 2. Healthcare utilization and expenditures in patients with atrial fibrillation treated with catheter ablation.
    Ladapo JA; David G; Gunnarsson CL; Hao SC; White SA; March JL; Reynolds MR
    J Cardiovasc Electrophysiol; 2012 Jan; 23(1):1-8. PubMed ID: 21777324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmic drug therapy and all-cause mortality after catheter ablation of atrial fibrillation: A propensity-matched analysis.
    Shantha G; Alyesh D; Ghanbari H; Yokokawa M; Saeed M; Cunnane R; Latchamsetty R; Crawford T; Jongnarangsin K; Bogun F; Pelosi F; Chugh A; Morady F; Oral H
    Heart Rhythm; 2019 Sep; 16(9):1368-1373. PubMed ID: 31201962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Antiarrhythmic Drug Initiation on Readmission After Catheter Ablation for Atrial Fibrillation.
    Noseworthy PA; Van Houten HK; Sangaralingham LR; Deshmukh AJ; Kapa S; Mulpuru SK; McLeod CJ; Asirvatham SJ; Friedman PA; Shah ND; Packer DL
    JACC Clin Electrophysiol; 2015 Aug; 1(4):238-244. PubMed ID: 29759312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of antiarrhythmic drugs during ablation of persistent atrial fibrillation: observations from a large single-centre cohort.
    Lüker J; Sultan A; Sehner S; Hoffmann B; Servatius H; Willems S; Steven D
    Heart Vessels; 2016 Oct; 31(10):1669-75. PubMed ID: 26546306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroke and Cardiovascular Events After Ablation or Antiarrhythmic Drugs for Treatment of Patients With Atrial Fibrillation.
    Mansour M; Heist EK; Agarwal R; Bunch TJ; Karst E; Ruskin JN; Mahapatra S
    Am J Cardiol; 2018 May; 121(10):1192-1199. PubMed ID: 29571722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the effect of prior antiarrhythmic drug use on the success of atrial fibrillation catheter ablation.
    Wang M; Tellor KB; Ramaswamy K; Krainik AJ; Armbruster AL
    J Clin Pharm Ther; 2019 Oct; 44(5):708-714. PubMed ID: 31056776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of catheter ablation of atrial fibrillation in Belgian practice: a cohort analysis on administrative data.
    Van Brabandt H; Neyt M; Devos C
    Europace; 2013 May; 15(5):663-8. PubMed ID: 23388182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart failure risk in patients with atrial fibrillation treated with catheter ablation vs antiarrhythmic drugs.
    Gruber M; Iglesias M; Khanna R; Zhang D; Karim S
    Heart Rhythm O2; 2023 Nov; 4(11):681-691. PubMed ID: 38034885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency catheter ablation maintains its efficacy better than antiarrhythmic medication in patients with paroxysmal atrial fibrillation: On-treatment analysis of the randomized controlled MANTRA-PAF trial.
    Raatikainen MJ; Hakalahti A; Uusimaa P; Nielsen JC; Johannessen A; Hindricks G; Walfridsson H; Pehrson S; Englund A; Hartikainen J; Kongstad O; Mortensen LS; Hansen PS;
    Int J Cardiol; 2015 Nov; 198():108-14. PubMed ID: 26163901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of restoration of sinus rhythm by extensive antiarrhythmic drugs in predicting results of catheter ablation of persistent atrial fibrillation.
    Igarashi M; Tada H; Sekiguchi Y; Yamasaki H; Arimoto T; Kuroki K; Machino T; Murakoshi N; Aonuma K
    Am J Cardiol; 2010 Jul; 106(1):62-8. PubMed ID: 20609649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of atrial fibrillation after a failed initial ablation procedure in patients with paroxysmal atrial fibrillation: a randomized comparison of drug therapy versus reablation.
    Pokushalov E; Romanov A; De Melis M; Artyomenko S; Baranova V; Losik D; Bairamova S; Karaskov A; Mittal S; Steinberg JS
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):754-60. PubMed ID: 23748210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of postprocedural antiarrhythmic drug therapy with bepridil on maintaining sinus rhythm after catheter ablation for persistent atrial fibrillation.
    Kondo T; Miake J; Kato M; Ogura K; Iitsuka K; Yamamoto K
    J Cardiol; 2016 Sep; 68(3):229-35. PubMed ID: 26654806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catheter ablation of inducible atrial flutter, in combination with atrial pacing and antiarrhythmic drugs ("hybrid therapy") improves rhythm control in patients with refractory atrial fibrillation.
    Prakash A; Saksena S; Krol RB; Filipecki A; Philip G
    J Interv Card Electrophysiol; 2002 Jun; 6(2):165-72. PubMed ID: 11992027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
    Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
    Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very long-term outcomes after a single catheter ablation procedure for the treatment of atrial fibrillation-the protective role of antiarrhythmic drug therapy.
    Mesquita J; Cavaco D; Ferreira AM; Costa FM; Carmo P; Morgado F; Mendes M; Adragão P
    J Interv Card Electrophysiol; 2018 Jun; 52(1):39-45. PubMed ID: 29511973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of antiarrhythmic drugs to maintain sinus rhythm after catheter ablation for atrial fibrillation: a meta-analysis.
    Xu X; Alida CT; Yu B
    Cardiovasc Ther; 2015 Aug; 33(4):242-6. PubMed ID: 26031448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality after catheter ablation for atrial fibrillation compared with antiarrhythmic drug therapy. A meta-analysis of randomized trials.
    Dagres N; Varounis C; Flevari P; Piorkowski C; Bode K; Rallidis LS; Tsougos E; Leftheriotis D; Sommer P; Hindricks G; Kremastinos DT
    Am Heart J; 2009 Jul; 158(1):15-20. PubMed ID: 19540387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited duration of antiarrhythmic drug use for newly diagnosed atrial fibrillation in a nationwide population under age 65.
    D'Angelo RN; Rahman M; Khanna R; Yeh RW; Goldstein L; Yadalam S; Kalsekar I; Tung P; Zimetbaum PJ
    J Cardiovasc Electrophysiol; 2021 Jun; 32(6):1529-1537. PubMed ID: 33760297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Short-Term Antiarrhythmic Drugs Use after Catheter Ablation of Atrial Fibrillation-A Systematic Review with Meta-Analyses and Trial Sequential Analyses of Randomized Controlled Trials.
    Chen W; Liu H; Ling Z; Xu Y; Fan J; Du H; Xiao P; Su L; Liu Z; Lan X; Zrenner B; Yin Y
    PLoS One; 2016; 11(5):e0156121. PubMed ID: 27224469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.